Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fei Tang

Showing results (591-600 of 633) with videos related to

Pageof 64
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2016
Controlled, Randomized, Open-Label Trial of Risk-Stratified Corticosteroid Prevention of Acute Graft-Versus-Host Disease After Haploidentical TransplantationYing-Jun Chang, Lan-Ping Xu, Yu Wang, et al.
Leukemia Research|May 31, 2016
Allogeneic hematopoietic cell transplantation for adult patients with treatment-related acute myeloid leukemia during first remission: Comparable to de novo acute myeloid leukemiaFei-Fei Tang, Xiao-Jun Huang, Xiao-Hui Zhang, et al.
Clinical and Translational Science|June 23, 2023
First-in-human phase 1 trial evaluating safety, pharmacokinetics, and pharmacodynamics of NLRP3 inflammasome inhibitor, GDC-2394, in healthy volunteersFei Tang, Rebecca Kunder, Tom Chu, et al.
British Journal of Haematology|April 27, 2024
A complete oral regimen for induction therapy of patients with high-risk APL: An oral etoposide instead of intravenous infusion for cytoreductive chemotherapyFei-Fei Tang, Wen-Bing Duan, Xiao-Hong Liu, et al.
British Journal of Haematology|November 15, 2018
Hepatitis E virus infection after haploidentical haematopoietic stem cell transplantation: incidence and clinical courseFei-Fei Tang, Xiao-Dong Mo, Yu Wang, et al.
Journal of Advanced Research|July 3, 2026
Development of optimized fluorogenic DNA aptamers for a portable one-pot CRISPR-Cas12a platform for rapid and sensitive detection of monkeypox virus and chikungunya virusXiao Wang, Weiyi Dong, Rong Shen, et al.
Antiviral Research|January 26, 2025
Immune evasion of Omicron variants JN.1, KP.2, and KP.3 to the polyclonal and monoclonal antibodies from COVID-19 convalescents and vaccine recipientsQian Wu, Hairuo Wu, Yabin Hu, et al.
Plant Science : an International Journal of Experimental Plant Biology|December 3, 2022
The F-box protein OsEBF2 confers the resistance to the brown planthopper (Nilparvata lugens Stål)Feilong Ma, Zixin Li, Sayi Wang, et al.
Scientific Reports|February 13, 2020
Prevalence and risk factors of having antibodies to class I and II human leukocyte antigens in older haploidentical allograft candidatesLe-Qing Cao, Meng Lv, Lan-Ping Xu, et al.
Journal of Hematology & Oncology|July 6, 2017
Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysisYing-Jun Chang, Yu Wang, Yan-Rong Liu, et al.
Pageof 64

Showing results (591-600 of 633) with videos related to

Sort By:
Pageof 64
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2016
Controlled, Randomized, Open-Label Trial of Risk-Stratified Corticosteroid Prevention of Acute Graft-Versus-Host Disease After Haploidentical TransplantationYing-Jun Chang, Lan-Ping Xu, Yu Wang, et al.
Leukemia Research|May 31, 2016
Allogeneic hematopoietic cell transplantation for adult patients with treatment-related acute myeloid leukemia during first remission: Comparable to de novo acute myeloid leukemiaFei-Fei Tang, Xiao-Jun Huang, Xiao-Hui Zhang, et al.
Clinical and Translational Science|June 23, 2023
First-in-human phase 1 trial evaluating safety, pharmacokinetics, and pharmacodynamics of NLRP3 inflammasome inhibitor, GDC-2394, in healthy volunteersFei Tang, Rebecca Kunder, Tom Chu, et al.
British Journal of Haematology|April 27, 2024
A complete oral regimen for induction therapy of patients with high-risk APL: An oral etoposide instead of intravenous infusion for cytoreductive chemotherapyFei-Fei Tang, Wen-Bing Duan, Xiao-Hong Liu, et al.
British Journal of Haematology|November 15, 2018
Hepatitis E virus infection after haploidentical haematopoietic stem cell transplantation: incidence and clinical courseFei-Fei Tang, Xiao-Dong Mo, Yu Wang, et al.
Journal of Advanced Research|July 3, 2026
Development of optimized fluorogenic DNA aptamers for a portable one-pot CRISPR-Cas12a platform for rapid and sensitive detection of monkeypox virus and chikungunya virusXiao Wang, Weiyi Dong, Rong Shen, et al.
Antiviral Research|January 26, 2025
Immune evasion of Omicron variants JN.1, KP.2, and KP.3 to the polyclonal and monoclonal antibodies from COVID-19 convalescents and vaccine recipientsQian Wu, Hairuo Wu, Yabin Hu, et al.
Plant Science : an International Journal of Experimental Plant Biology|December 3, 2022
The F-box protein OsEBF2 confers the resistance to the brown planthopper (Nilparvata lugens Stål)Feilong Ma, Zixin Li, Sayi Wang, et al.
Scientific Reports|February 13, 2020
Prevalence and risk factors of having antibodies to class I and II human leukocyte antigens in older haploidentical allograft candidatesLe-Qing Cao, Meng Lv, Lan-Ping Xu, et al.
Journal of Hematology & Oncology|July 6, 2017
Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysisYing-Jun Chang, Yu Wang, Yan-Rong Liu, et al.
Pageof 64